In the European Health study conducted by InSites Consulting, which included 2,800 participants, seven out of 10 people indicated the ability to differentiate generic medicines from branded drugs. While generic medicines contain the same active ingredients as patented brands, the study still revealed that 44% of patients who claim to be familiar with generic medicines do not believe this.
However, this does not detract from the effectiveness patients ascribe to 'white products,' says InSites. 83% of responders believe that generic medicines are equally effective as the original formula.
71% of patients claim to know the difference between generic medicines and brand medicines. Those able to differentiate generic medicines from brand medicines are - in comparison to the general population - on average slightly higher educated. The 45+ age group is also more familiar with generic alternatives than younger patients, and men more so than women.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze